Molecular interactions of full-length and truncated GIP peptides with the GIP receptor – A comprehensive review-Reference-Cited by-同舟云学术

Molecular interactions of full-length and truncated GIP peptides with the GIP receptor – A comprehensive review

Published:2020-03 Issue: Volume:125 Page:170224
ISSN:0196-9781
Container-title:Peptides
language:en
Short-container-title:Peptides

Author:

Gabe Maria Buur Nordskov,van der Velden Wijnand J.C.,Smit Florent Xavier,Gasbjerg Lærke Smidt^ORCID,Rosenkilde Mette Marie^ORCID

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Endocrinology,Physiology,Biochemistry

Reference105 articles.

1. Biology of Incretins: GLP-1 and GIP;Baggio;Gastroenterology,2007

2. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations;Nauck;J. Clin. Endocrinol. Metab.,1993

3. Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects;Vilsbøll;Regul. Pept.,2003

4. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics;Fagerberg;Mol. Cell Proteomics,2014

5. GIP increases adipose tissue expression and blood levels of MCP-1 in humans and links high energy diets to inflammation: a randomised trial;Gögebakan;Diabetologia,2015

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into the structure and activation mechanism of some class B1 GPCR family members;Molecular Biology Reports;2024-09-06

2. GIP-derived GIP receptor antagonists – a review of their role in GIP receptor pharmacology;Peptides;2024-07

3. GLP-1/GIP Agonist as an Intriguing and Ultimate Remedy for CombatingAlzheimer’s Disease through its Supporting DPP4 Inhibitors: A Review;Current Topics in Medicinal Chemistry;2024-07

4. Duodenal enteroendocrine cells and GIP as treatment targets for obesity and type 2 diabetes;Peptides;2024-04

5. Spatiotemporal regulation of GIPR signaling impacts glucose homeostasis as revealed in studies of a common GIPR variant;Molecular Metabolism;2023-12